We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Sep 2022
  • Code : CMI5261
  • Pages :174
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Nasal sprays are used to locally or systemically provide drugs to the nasal cavities. They are applied locally to treat problems such as allergic rhinitis and nasal congestion. When a medicine is administered nasally, it is absorbed via the nasal mucosa rather than entering the respiratory tract. It is marketed as a different, non-invasive route that may be utilized for both local and systemic therapy and is particularly helpful when dealing with medications that are highly metabolized or unstable in the GI (gastrointestinal) medium.

US Nasal Spray Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 610 million cases and 6.51 million deaths due to coronavirus (COVID-19) were reported till September 22, 2022, across the globe.

Impact of COVID-19 on Demand and Supply of Nasal Spray

The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products.

However, the COVID-19 pandemic has increased research and development for the use of nasal spray for the treatment and prevention of coronavirus infection. This is assisting in the market growth, which is expected to boost the U.S. nasal spray market growth over the forecast period. For instance, in 2021, scientists at the University of Pennsylvania and Regeneron, a biotechnology company, announced that they were collaborating and investigating whether technology developed for Adeno-Associated Virus (AAV) gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.

US Nasal Spray Market is estimated to be valued at US$ 9,272.8 Mn in 2022, and is expected to exhibit a CAGR of 6.8% over the forecast period (2022-2030).

Figure 1: U.S. Nasal Spray Market Share (%) Analysis, By Type, 2022

U.S. NASAL SPRAY MARKET

To learn more about this report, request a free sample copy

Increasing incidence of allergic rhinitis is expected to drive growth of market over the forecast period.

Increasing incidence of allergic rhinitis is expected to fuel growth of the U.S. nasal spray market over the forecast period. For instance, according to Asthma and Allergy Foundation of America, in the U. S., seasonal allergic rhinitis was diagnosed in about 24 million people in 2018 (hay fever) which includes 8% (19.2 million) of adults and 7% (5.2 million) of children. In 2018, compared to black children, white children showed a higher prevalence of hay fever.

U.S. Nasal Spray Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 9,272.8 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 6.8% 2030 Value Projection: US$ 15,723.5 Mn
Geographies covered:
  • U.S.
Segments covered:
  • By Type: Prescription Based (Branded, Generic), Over the Counter (Branded, Generic)
  • By Product Type: Prescription Based (Steroid Sprays (Beclomethasone, Azelastine Hydrochloride And Fluticasone Propionate, Flunisolide, Mometasone Furoate, Fluticasone, Triamcinolone Acetonide, Budesonide, Others), Antihistamine Sprays (Azelastine, Olopatadine Hydrochloride), Decongestant Sprays (Oxymetazoline), Others (Ipratropium Bromide, Naloxone, Others)), Over the Counter (Steroid Sprays (Fluticasone, Triamcinolone, Budesonide), Decongestant Sprays (Oxymetazoline, Phenylephrine, Xylometazoline), Saline Nasal Spray, Others (Cromoglicic acid (NasalCrom)))
  • By Indication: Allergic Rhinitis, Nasal Allergies, Nasal Congestion, Others
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

GlaxoSmithKline plc, Sanofi S.A., Bayer AG, Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Pfizer Inc., Procter & Gamble, AstraZeneca Plc., NeilMed Pharmaceuticals Inc., Church & Dwight Co., Inc., and Neurelis, Inc

Growth Drivers:
  • Increasing incidence of allergic rhinitis
  • Advantages of using nasal sprays 
Restraints & Challenges:
  • Increasing number of product recalls by market players

Figure 2: U.S. Nasal Spray Market Value (US$ Mn) Analysis and Forecast and Y-o-Y Growth (%), 2017-2030

U.S. NASAL SPRAY MARKET

To learn more about this report, request a free sample copy

Advantages of using nasal sprays are expected to boost the U.S. nasal spray market growth over the forecast period.

There are various benefits of using nasal route of administration and nasal sprays for drug delivery, this is expected to fuel the U.S. nasal spray market growth over the forecast period. Benefits of using saline nasal sprays include –

  • Saline nasal sprays aid in clearing the nose of allergies, viruses, and other irritants
  • It helps to hydrate and clean nasal tissues, which is crucial for maintaining nasal immunity
  • When nasal saline is administered initially, the effectiveness of medicinal nasal sprays may be increased
  • The spray also thins extra mucus in the sinuses and nose, which can relieve discomfort and congestion

Restraint- US Nasal Spray Market

Due to regulatory standards not being met, market players are recalling their nasal sprays. This is expected to hinder growth of the U.S. nasal spray market over the forecast period. The following products were recalled:

  • Maximum Strength Plus Menthol No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 72288-703-10), from batches 1FK1251 (Exp. 2/28/23) and 1BK0716 (Exp. 12/31/22), distributed by Amazon.com Services;
  • Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 50594-719-10), from batch 1BK0827 (Exp. 12/31/22), packaged by Perrigo Company for Big Lots Stores Inc.;
  • Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 41520-108-10), from batches 1BK0716 (Exp. 12/31/22) and 1FK1251 (Exp. 2/28/23), distributed by Foodhold USA, and many more

US Nasal Spray Market – Competitive Landscape

Major players operating in the U.S. nasal spray market are GlaxoSmithKline plc, Sanofi S.A., Bayer AG, Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Pfizer Inc., Procter & Gamble, AstraZeneca Plc., NeilMed Pharmaceuticals Inc., Church & Dwight Co., Inc., and Neurelis, Inc.

Frequently Asked Questions

U.S. nasal spray market is expected to exhibit a CAGR of 6.8% during the forecast period (2022-2030).

The market is estimated to be valued at US$ 9,272.8 million in 2022.

GlaxoSmithKline plc, Sanofi S.A., Bayer AG, Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Pfizer Inc., Procter & Gamble, AstraZeneca Plc., NeilMed Pharmaceuticals Inc., Church & Dwight Co., Inc., and Neurelis, Inc. re some of the prominent players operating in the market.

The market is expected to be valued at US$ 15,723.5 million in 2030.

Increasing incidence of allergic rhinitis and advantages of using nasal sprays are some of the driving factors, which are expected to drive growth of the market.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo